DESJARDINS, Clarissa,GROGAN, Donna Roy,PACKMAN, Jeffrey Neal,HARNETT, Mark
申请号：
EP17809505
公开号：
EP3468554A4
申请日:
2017.06.08
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
